These findings also have major implications for management of pandemic influenza, where asthma is a major risk factor for severe disease and death [28], as replacing deficient anti-viral immune proteins such as IFN-β and now IL-15, may have therapeutic potential to ameliorate severity of disease and perhaps prevent death. Here, IL15 is linked to asthma.